Cargando…

Selective Targeting of Tumor and Stromal Cells By a Nanocarrier System Displaying Lipidated Cathepsin B Inhibitor**

Cathepsin B (CtsB) is a lysosomal cysteine proteinase that is specifically translocated to the extracellular milieu during cancer progression. The development of a lipidated CtsB inhibitor incorporated into the envelope of a liposomal nanocarrier (LNC-NS-629) is described. Ex vivo and in vivo studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mikhaylov, G, Klimpel, D, Schaschke, N, Mikac, U, Vizovisek, M, Fonovic, M, Turk, V, Turk, Boris, Vasiljeva, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2014
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499245/ https://www.ncbi.nlm.nih.gov/pubmed/24975267 http://dx.doi.org/10.1002/anie.201402305

Ejemplares similares

A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A
por: Kozak, Andreja, et al.
Publicado: (2023)

Theranostic Applications of an Ultra-Sensitive T(1) and T(2) Magnetic Resonance Contrast Agent Based on Cobalt Ferrite Spinel Nanoparticles
por: Mikhaylov, Georgy, et al.
Publicado: (2022)

Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy
por: Mitrović, Ana, et al.
Publicado: (2022)

Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment
por: Vidak, Eva, et al.
Publicado: (2019)

Cysteine cathepsins: From structure, function and regulation to new frontiers()
por: Turk, Vito, et al.
Publicado: (2012)

Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target
por: Reinheckel, Thomas, et al.
Publicado: (2012)

Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin
por: Kramer, Lovro, et al.
Publicado: (2017)

In Vivo Imaging of Mouse Tumors by a Lipidated Cathepsin S Substrate**
por: Hu, Hai-Yu, et al.
Publicado: (2014)

Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins
por: Tušar, Livija, et al.
Publicado: (2023)

Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples
por: Poreba, Marcin, et al.
Publicado: (2019)

Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes
por: Poreba, Marcin, et al.
Publicado: (2018)

The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer †
por: Stoka, Veronika, et al.
Publicado: (2023)

Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells
por: Završnik, Janja, et al.
Publicado: (2017)

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
por: Mirković, Bojana, et al.
Publicado: (2015)

Salivary Tick Cystatin OmC2 Targets Lysosomal Cathepsins S and C in Human Dendritic Cells
por: Zavašnik-Bergant, Tina, et al.
Publicado: (2017)

The Acute Phase Response Is a Prominent Renal Proteome Change in Sepsis in Mice
por: Róka, Beáta, et al.
Publicado: (2019)

Identification and characterization of the novel reversible and selective cathepsin X inhibitors
por: Fonović, Urša Pečar, et al.
Publicado: (2017)

Proteolysis of Gingival Keratinocyte Cell Surface Proteins by Gingipains Secreted From Porphyromonas gingivalis – Proteomic Insights Into Mechanisms Behind Tissue Damage in the Diseased Gingiva
por: Hočevar, Katarina, et al.
Publicado: (2020)

Cysteine Cathepsin Activity Regulation by Glycosaminoglycans
por: Novinec, Marko, et al.
Publicado: (2014)

Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors
por: Majc, Bernarda, et al.
Publicado: (2022)

Novel Opportunities for Cathepsin S Inhibitors in Cancer Immunotherapy by Nanocarrier-Mediated Delivery
por: Fuchs, Natalie, et al.
Publicado: (2020)

Computational Indicator Approach for Assessment of Nanotoxicity of Two-Dimensional Nanomaterials
por: Tsukanov, Alexey A., et al.
Publicado: (2022)

Profilin 1 as a Target for Cathepsin X Activity in Tumor Cells
por: Pečar Fonović, Urša, et al.
Publicado: (2013)

The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K
por: Mons, Elma, et al.
Publicado: (2019)

Improved Cathepsin Probes for Sensitive Molecular Imaging
por: Yitzhak, Yonit, et al.
Publicado: (2022)

The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors
por: Pišlar, Anja, et al.
Publicado: (2020)

Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation
por: Balaji, Kithiganahalli N., et al.
Publicado: (2002)

Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis
por: Pečar Fonović, Urša, et al.
Publicado: (2015)

Cathepsin D—Managing the Delicate Balance
por: Mijanovic, Olja, et al.
Publicado: (2021)

Identification of Desmoglein-2 as a novel target of Helicobacter pylori HtrA in epithelial cells
por: Bernegger, Sabine, et al.
Publicado: (2021)

Unnatural amino acids increase activity and specificity of synthetic substrates for human and malarial cathepsin C
por: Poreba, Marcin, et al.
Publicado: (2014)

A novel FRET peptide assay reveals efficient Helicobacter pylori HtrA inhibition through zinc and copper binding
por: Bernegger, Sabine, et al.
Publicado: (2020)

Photodynamic Quenched Cathepsin Activity Based Probes for Cancer Detection and Macrophage Targeted Therapy
por: Ben-Nun, Yael, et al.
Publicado: (2015)

Mice with Catalytically Inactive Cathepsin A Display Neurobehavioral Alterations
por: Calhan, O. Y., et al.
Publicado: (2017)

Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases
por: Tušar, Livija, et al.
Publicado: (2021)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months’ Restenosis of the Femoropopliteal Artery
por: Mijovski, Mojca Bozic, et al.
Publicado: (2018)

Lipid-Based Nanocarriers for RNA Delivery
por: Xue, Hui Yi, et al.
Publicado: (2015)

Lipid-Based Nanocarriers for The Treatment of Glioblastoma
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2020)

Lipid Nanocarriers for Hyperproliferative Skin Diseases
por: Souto, Eliana B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oh9aoplmn8ltu2qob10tmiugpi